Biological therapies such as anti-IgE monoclonal antibody, IL-4 receptor alpha subunit antagonist, and anti-IL-5 are promising treatments for nasal polyps and could significantly improve olfaction (Gevaert et al., 2013; Bachert et al., 2016, 2017). Here, IGHE is linked to nasal cavity polyp.